Cardinal Health, Inc.

+0.52 (+1.06%)
Divestitures / Spin-offs, Other Pre-Announcement, Mergers / Acquisitions

Cardinal To Sell Cordis Business To Hellman & Friedman In About $1 Bln Deal

Published: 03/12/2021 14:23 GMT
Cardinal Health, Inc. (CAH) - Cardinal Health Signs Definitive Agreement to Sell Its Cordis Business to Hellman & Friedman.
Cardinal Health Inc - Deal for Approximately $1 Billion.
Cardinal Health - Divestiture of Cordis Business to Decrease Medical Segment Profit by About $60 Million to $70 Million on Annual Run-rate Basis.
Cardinal Health Inc - Co Was Authorized to Incur Costs Associated With Planned Divestiture of Up to $125 Million, Primarily in Its Fiscal Years 2021, 2022.
Cardinal Health - to Retain Full Authority for Lawsuits Related to Inferior Vena Cava Filters in U.S., Canada, and Liability Associated With These Matters.
Cardinal Health Inc - Expects to Result in a Pre-tax Loss of Up to $120 Million in Q3 2021 From Cordis Business Sale.